Objetivo Elaborar unas recomendaciones que sirvan de referencia a los reumatólogos y
otros profesionales implicados en el tratamiento del lupus eritematoso sistémico (LES) que …

Background Systemic lupus erythematosus (SLE) is a common systemic autoimmune
disease with a complex genetic inheritance. Genome-wide association studies (GWAS) have …

Objective: Systemic lupus erythematosus (SLE) is associated to boosted atherosclerosis
development and a higher cardiovascular disease risk. This study aimed to delineate the role of …

Objective Clinical heterogeneity, a hallmark of systemic autoimmune diseases, impedes
early diagnosis and effective treatment, issues that may be addressed if patients could be …

Objective This study aimed to elucidate the presence, antigen specificities, and potential clinical
associations of anti–neutrophil extracellular trap (anti‐NET) antibodies in a multinational …

Objective To provide a reference to rheumatologists and other physicians involved in the
treatment of systemic lupus erythematosus (SLE) who are using, or about to use biologic …

Background Systemic lupus erythematosus (SLE) is a genetically complex rheumatic
disease characterized by heterogeneous clinical manifestations of unknown etiology. Recent …

Objective This study aimed to use cluster analysis (CA) to identify different clinical phenotypes
among antiphospholipid antibodies (aPL)-positive patients. Methods The Alliance for …

Objective This article aims to analyse the rate of antiphospholipid antibodies (aPL)
negativisation in patients with antiphospholipid syndrome (APS), and to evaluate potential new …

Objective To describe the baseline characteristics of patients with positivity for antiphospholipid
antibodies (aPLs) who were enrolled in an international registry, the Antiphospholipid …